What Is Chemotherapy Waste and Why Is It Highly Regulated?

Chemotherapy waste is among the most tightly regulated categories of medical waste in the United States, and for good reason. The same drugs that fight cancer are, in many cases, classified as hazardous under federal law because of their toxicity, carcinogenicity, and potential to cause reproductive harm. For hospitals, infusion centers, veterinary oncology practices, and specialty pharmacies, understanding how chemotherapy waste is defined and regulated isn’t optional — it’s essential to protecting staff, patients, and the environment, and to avoiding costly regulatory violations. At RedBags, we help healthcare facilities of every size navigate these rules with confidence.

What Exactly Is Chemotherapy Waste?

Chemotherapy waste, often called “chemo waste,” includes any materials contaminated with antineoplastic (cancer-fighting) drugs. This covers empty and partially empty drug vials, IV bags and tubing, syringes, gloves, gowns, absorbent pads, and any other item that has come into contact with a chemotherapy agent. Because these drugs are designed to kill rapidly dividing cells, exposure — even in trace amounts — can pose serious health risks to nurses, pharmacists, housekeeping staff, and waste handlers.

The Regulatory Framework: RCRA and Beyond

The U.S. Environmental Protection Agency (EPA) regulates certain chemotherapy drugs under the Resource Conservation and Recovery Act (RCRA), the same federal law that governs hazardous waste from industrial facilities. Under RCRA, a small number of chemotherapy agents — including arsenic trioxide (P012) — are classified as “P-listed” acutely hazardous wastes, while others such as cyclophosphamide, melphalan, and mitomycin C fall under the “U-listed” category of hazardous waste. Facilities that generate P-listed or U-listed waste in reportable quantities must manage it according to strict RCRA generator requirements, including manifesting, labeling, and disposal only through a permitted treatment, storage, and disposal facility (TSDF).

Trace Chemo Waste vs. Bulk Chemo Waste

Not all chemo waste is treated the same way. Facilities generally separate it into two streams: trace chemotherapy waste (items like empty IV bags, tubing, and PPE that contained less than 3% residual drug by weight, per RCRA’s “empty container” rule) and bulk chemotherapy waste (spill materials, unused drugs, or containers with more than trace residue). Trace waste is typically collected in yellow chemo waste containers and incinerated, while bulk RCRA hazardous chemo waste must go into black RCRA hazardous waste containers and be manifested to a permitted hazardous waste facility. Mixing these streams is one of the most common — and most costly — compliance mistakes we see.

USP <800> and OSHA: The Handling Side of Compliance

Beyond disposal, USP General Chapter <800>, enforceable in most states through pharmacy boards and accreditation bodies, sets standards for the safe handling of hazardous drugs, including engineering controls, personal protective equipment, and closed-system transfer devices. OSHA’s guidance on hazardous drugs complements USP <800> by outlining employer responsibilities for training, exposure monitoring, and medical surveillance. Together, these frameworks work upstream of disposal to reduce the amount of contamination that becomes chemo waste in the first place — but every facility still needs a compliant downstream disposal partner like RedBags to close the loop safely.

Why Improper Disposal Is So Risky

Chemotherapy agents that end up in regular trash or standard medical waste streams can contaminate landfills, wastewater, and incinerator ash, and can expose sanitation workers to carcinogenic and mutagenic compounds. Regulatory penalties for RCRA violations can reach tens of thousands of dollars per day per violation, and facilities found out of compliance often face reputational damage on top of fines. RedBags designs chemo waste programs specifically to prevent these outcomes, from proper container placement to documented chain-of-custody disposal.

Best Practices for Managing Chemo Waste

• Segregate trace and bulk chemo waste at the point of generation using clearly labeled yellow and black containers.
• Train all staff who handle hazardous drugs on RCRA, USP <800>, and OSHA requirements at least annually.
• Maintain complete hazardous waste manifests and retain records for the state-required retention period.
• Never place chemo-contaminated items in red bag medical waste or regular trash containers.
• Partner with a licensed hazardous and medical waste hauler for both trace and bulk chemo streams.

Because the rules vary by state and by the specific drugs your facility handles, working with an experienced partner like RedBags takes the guesswork out of compliance. We provide the right containers, pickup schedules, and documentation so your team can focus on patient care instead of regulatory paperwork.